Topotecan is a potent inhibitor of SUMOylation in glioblastoma multiforme and alters both cellular replication and metabolic programming. (2017)

First Author: Bernstock J
Attributed to:  Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.16909

Publication URI: https://www.repository.cam.ac.uk/handle/1810/270096

Type: Journal Article/Review